Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human Proprotein Convertase 9/PCSK9 (Research Grade Alirocumab Biosimilar) Alexa Fluor 700-conjugated Antibody, R&D Systems™
GREENER_CHOICE

Human Monoclonal Antibody

Supplier:  R&D Systems IC10347N100UG

Catalog No. IC10347N100


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

Proprotein Convertase 9/PCSK9 Monoclonal specifically detects Proprotein Convertase 9/PCSK9 in Human samples. It is validated for Intracellular Staining by Flow Cytometry.
Specifications

Specifications

Proprotein Convertase 9/PCSK9
Monoclonal
Alexa Fluor 700
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Human
Protein A or G purified from cell culture supernatant
RUO
255738
Protect from light. Do not freeze. 12 months from date of receipt, 2 to 8°C as supplied.
IgG1
Flow Cytometry
Hu135
Intracellular Staining by Flow Cytometry 0.25-1 ug/10^6 cells
EC 3.4.21, EC 3.4.21.111, FH3, FH3neural apoptosis regulated convertase 1, FHCL3, HCHOLA3, hypercholesterolemia, autosomal dominant 3, LDLCQ1, NARC1, NARC-1, NARC-1convertase subtilisin/kexin type 9 preproprotein, NARC1EC 3.4.21.-, Neural apoptosis-regulated convertase 1, PC9, PCSK9, Proprotein convertase 9, proprotein convertase subtilisin/kexin type 9, Subtilisin/kexin-like protease PC9
Human Proprotein Convertase 9/PCSK9
100 μg
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.